BACKGROUND & AIMS: Mallory-Denk bodies (MDBs) are keratin (K)-rich cytoplasmic hepatocyte inclusions commonly associated with alcoholic steatohepatitis. Given the significant gender differences in predisposition to human alcohol-related liver injury, and the strain difference in mouse MDB formation, we hypothesized that sex affects MDB formation. METHODS: MDBs were induced in male and female mice overexpressing K8, which are predisposed to MDB formation, and in nontransgenic mice by feeding the porphyrinogenic compound 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). MDB presence was determined by histologic, immunofluorescence, and biochemical analyses and correlated to liver injury using serologic and pathologic markers. Cytoskeletal and metabolic liver protein analysis, in vitro metabolism studies, and measurement of oxidative stress markers and protoporphyrin-IX were performed. RESULTS: Male mice formed significantly more MDBs, which was attenuated modestly by estradiol. MDB formation was accompanied by increased oxidative stress. Female mice had significantly fewer MDBs and oxidative stress-related changes, but had increased ductular reaction protoporphyrin-IX accumulation, and MDB-preventive K18 induction. Evaluation of the microsomal cytochrome-P450 (CYP) enzymes revealed significant gender differences in protein expression and activity in untreated and DDC-fed mice, and showed that DDC is metabolized by CYP3A. The changes in CYPs account for the gender differences in porphyria and DDC metabolism. DDC metabolite formation and oxidative injury accumulate on chronic DDC exposure in males, despite more efficient acute metabolism in females. CONCLUSIONS: Gender dimorphic formation of MDBs and porphyria associate with differences in CYPs, oxidative injury, and selective keratin induction. These findings may extend to human MDBs and other neuropathy- and myopathy-related inclusions. 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
BACKGROUND & AIMS: Mallory-Denk bodies (MDBs) are keratin (K)-rich cytoplasmic hepatocyte inclusions commonly associated with alcoholic steatohepatitis. Given the significant gender differences in predisposition to humanalcohol-related liver injury, and the strain difference in mouseMDB formation, we hypothesized that sex affects MDB formation. METHODS:MDBs were induced in male and female mice overexpressing K8, which are predisposed to MDB formation, and in nontransgenic mice by feeding the porphyrinogenic compound 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). MDB presence was determined by histologic, immunofluorescence, and biochemical analyses and correlated to liver injury using serologic and pathologic markers. Cytoskeletal and metabolic liver protein analysis, in vitro metabolism studies, and measurement of oxidative stress markers and protoporphyrin-IX were performed. RESULTS: Male mice formed significantly more MDBs, which was attenuated modestly by estradiol. MDB formation was accompanied by increased oxidative stress. Female mice had significantly fewer MDBs and oxidative stress-related changes, but had increased ductular reaction protoporphyrin-IX accumulation, and MDB-preventive K18 induction. Evaluation of the microsomal cytochrome-P450 (CYP) enzymes revealed significant gender differences in protein expression and activity in untreated and DDC-fed mice, and showed that DDC is metabolized by CYP3A. The changes in CYPs account for the gender differences in porphyria and DDC metabolism. DDC metabolite formation and oxidative injury accumulate on chronic DDC exposure in males, despite more efficient acute metabolism in females. CONCLUSIONS: Gender dimorphic formation of MDBs and porphyria associate with differences in CYPs, oxidative injury, and selective keratin induction. These findings may extend to humanMDBs and other neuropathy- and myopathy-related inclusions. 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Authors: U A Badrising; M Maat-Schieman; S G van Duinen; F Breedveld; P van Doorn; B van Engelen; F van den Hoogen; J Hoogendijk; C Höweler; A de Jager; F Jennekens; P Koehler; H van der Leeuw; M de Visser; J J Verschuuren; A R Wintzen Journal: Neurology Date: 2000-11-14 Impact factor: 9.910
Authors: Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters Journal: Toxicol Sci Date: 2002-02 Impact factor: 4.849
Authors: Chitra Sridar; Theunis C Goosen; Ute M Kent; J Andrew Williams; Paul F Hollenberg Journal: Drug Metab Dispos Date: 2004-06 Impact factor: 3.922
Authors: Raymond Kwan; Shinichiro Hanada; Masaru Harada; Pavel Strnad; Daniel H Li; M Bishr Omary Journal: FASEB J Date: 2012-02-23 Impact factor: 5.191
Authors: Diana M Toivola; Aida Habtezion; Julia O Misiorek; Linxing Zhang; Joel H Nyström; Orr Sharpe; William H Robinson; Raymond Kwan; M Bishr Omary Journal: FASEB J Date: 2015-09-23 Impact factor: 5.191
Authors: Ayako Suzuki; Manal F Abdelmalek; Jeffrey B Schwimmer; Joel E Lavine; Ann O Scheimann; Aynur Unalp-Arida; Katherine P Yates; Arun J Sanyal; Cynthia D Guy; Anna Mae Diehl Journal: Clin Gastroenterol Hepatol Date: 2012-02-14 Impact factor: 11.382
Authors: Amika Singla; David S Moons; Natasha T Snider; Elizabeth R Wagenmaker; V Bernadene Jayasundera; M Bishr Omary Journal: Hepatology Date: 2012-04-25 Impact factor: 17.425
Authors: Harvinder Saggi; Dhiman Maitra; An Jiang; Rong Zhang; Pengcheng Wang; Pamela Cornuet; Sucha Singh; Joseph Locker; Xiaochao Ma; Harry Dailey; Marc Abrams; M Bishr Omary; Satdarshan P Monga; Kari Nejak-Bowen Journal: J Hepatol Date: 2018-10-01 Impact factor: 25.083
Authors: Natasha T Snider; Nicholas W Griggs; Amika Singla; David S Moons; Sujith V W Weerasinghe; Anna S Lok; Chunhai Ruan; Charles F Burant; Hari S Conjeevaram; M Bishr Omary Journal: Hepatology Date: 2013-08-26 Impact factor: 17.425